KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Share-based Compensation (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Share-based Compensation for 16 consecutive years, with $7.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 33.81% to $7.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.0 million, a 25.64% decrease, with the full-year FY2025 number at $23.0 million, down 25.64% from a year prior.
  • Share-based Compensation was $7.1 million for Q4 2025 at Biolife Solutions, up from $5.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $10.7 million in Q4 2024 to a low of $2.5 million in Q1 2021.
  • A 5-year average of $6.4 million and a median of $6.1 million in 2022 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: skyrocketed 211.99% in 2021, then crashed 41.55% in 2024.
  • Biolife Solutions' Share-based Compensation stood at $5.1 million in 2021, then skyrocketed by 51.29% to $7.7 million in 2022, then rose by 29.3% to $9.9 million in 2023, then increased by 7.91% to $10.7 million in 2024, then plummeted by 33.81% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Share-based Compensation are $7.1 million (Q4 2025), $5.9 million (Q3 2025), and $5.9 million (Q2 2025).